A cross-sectional study that included 175 patients with luminal B HER2-positive tumours showed that these patients had a 2 times higher risk of having a waist circumference of ≥80 cm and a 3 times higher CRP compared to luminal A patients [70]. Here, ERBB2 is linked to neoplasm.